222 related articles for article (PubMed ID: 3515679)
1. Dallas experience with cyclosporine A (CsA) one to six months posttransplant.
Hull AR; Atkins CR; Brinker KR; Dawidson I; Dickerman RM; Emerson W; Helderman JH; Levitz B; Long DL; Nesser D
Transplant Proc; 1986 Apr; 18(2 Suppl 1):128-31. PubMed ID: 3515679
[No Abstract] [Full Text] [Related]
2. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
[No Abstract] [Full Text] [Related]
3. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
MacDonell RC; Johnson K; Richie R; Nylander W; McMahon Y; Niblack G; Green W; Morrissey J; Ynares C
Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
[No Abstract] [Full Text] [Related]
4. Monotherapy with cyclosporine in kidney transplantation.
Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
[No Abstract] [Full Text] [Related]
5. Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction.
Thistlethwaite JR; Woodle ES; Mayes JT; Stuart JK; Heffron TG; Spargo BH; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1890-2. PubMed ID: 2652614
[No Abstract] [Full Text] [Related]
6. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
[No Abstract] [Full Text] [Related]
7. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
Cole E; Robinson C; Bear R
Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
[No Abstract] [Full Text] [Related]
8. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
Woodle ES; Heffron TG; Stuart JK; Thistlethwaite JR; Stuart FP
Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
[No Abstract] [Full Text] [Related]
9. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
[No Abstract] [Full Text] [Related]
10. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
11. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
Light JA; Aquino A; Ali A; Rodriguez R; Ali S
Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
[No Abstract] [Full Text] [Related]
12. Quadruple therapy for cadaver renal transplantation.
Deierhoi MH; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
[No Abstract] [Full Text] [Related]
13. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
Hourmant M; Soulillou JP
Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
[TBL] [Abstract][Full Text] [Related]
14. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
Simonton SC; Sibley RK; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
[No Abstract] [Full Text] [Related]
15. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
16. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
[No Abstract] [Full Text] [Related]
17. Definition, diagnosis, and management of rejection in the second to sixth months posttransplant--an overview.
Matas AJ; Tellis VA; Quinn T; Soberman R; Veith FJ
Transplant Proc; 1986 Apr; 18(2 Suppl 1):141-50. PubMed ID: 3515682
[TBL] [Abstract][Full Text] [Related]
18. Renal transplantation without prednisolone: effects of bone marrow tolerance azathioprine.
Schulak JA; Moritz CE; Hricik DE
Transplant Proc; 1989 Feb; 21(1 Pt 2):1709-11. PubMed ID: 2652560
[No Abstract] [Full Text] [Related]
19. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipient.
Tolkoff-Rubin NE; Rubin RH
Transplant Proc; 1986 Apr; 18(2 Suppl 1):168-76. PubMed ID: 3008389
[No Abstract] [Full Text] [Related]
20. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
Sutherland DE; Fryd DS; Strand M; Ascher N; Simmons RL; Najarian JS
Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
